Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage

Alcoholism: Clinical and Experimental Research

Volumn 21, Issue 8, 1997, Pages 1435-1439

  Gardell, Luis R ^a   Whalen, Christine A ^a   Chattophadyay, Soma ^a   Cavallaro, Colleen A ^a   Hubbell, Christopher L ^a   Reid, Larry D ^a  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Alcohol consumption; Fluoxetine; Naltrexone; Opioids; Serotonin

Indexed keywords

ALCOHOL; FLUOXETINE; NALTREXONE; SEROTONIN UPTAKE INHIBITOR;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DATA ANALYSIS; MONKEY; NONHUMAN; PRIORITY JOURNAL; RAT; RODENT;

EID: 0030712381     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1997.tb04473.x     Document Type: Article

References (20)

1. Altshuler HL, Phillips PE, Feinhandler DA: Alteration of ethanol self-administration by naltrexone. Life Sci 26:679-688, 1980
2. Froehlich JC: Genetic factors in alcohol self-administration. J Clin Psychiatry 56(Suppl. 7):15-23, 1995
3. Gardell LR, Hubbell CL, Reid LD: Naltrexone persistently reduces rats' intake of a palatable alcoholic beverage. Alcohol Clin Exp Res 20:584-588, 1996
4. Gianoulakis C: Endogenous opioids and excessive alcohol consumption. J Psychiatric Neurosci 18:148-156, 1993
5. Hubbell CL, Czirr SA, Hunter GA, Beaman CM, LeCann NC, Reid LD: Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations. Alcohol 3:39-54, 1986
6. Hubbell CL, Marglin SH, Spitalnic SJ, Abelson ML, Wild KD, Reid LD: Opioidergic, serotonergic, and dopaminergic manipulations and rats' intake of a sweetened alcoholic beverage. Alcohol 8:355-367, 1991
7. Reid LD: Endogenous opioids and alcohol dependence: Opioid alkaloids and the propensity to drink alcoholic beverages. Alcohol 13:5-11, 1996
8. Reid LD, Gardell LR, Chattopadhyay S, Hubbell CL: Periodic naltrexone and ethanol intake. Alcohol Clin Exp Res 20:1329-1334, 1996
9. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP: Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880, 1992
10. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B: Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Arch Gen Psychiatry 49:881-887, 1992
11. Messiha FS: Fluoxetine: A spectrum of clinical applications and postulates of underlying mechanisms. Neurosci Biobehav Rev 17:385-396, 1993
12. McBride WJ, Murphy JM, Yoshimoto K, Lumeng L, Li T-K: Serotonin mechanisms and alcohol drinking behavior. Drug Dev Res 30:170-177, 1993
13. Cornelius JR, Salloum IM, Cornelius MD, Perel JM, Ehler JG, Jarrett PJ, Levin RL, Black A, Mann JJ: Preliminary report: Double-blind, placebo-controlled study of fluoxetine in depressed alcoholics. Psychopharmacol Bull 31:297-303, 1995
14. Gorelick DA, Paredes A: Effects of fluoxetine on alcohol consumption in male alcoholics. Alcohol Clin Exp Res 16:19-23, 1992
15. Naranjo CA, Poulos CX, Bremner KE, Lanctot KL: Fluoxetine attenuates alcohol intake and desire to drink. Int Clin Psychopharmacol 9:163-172, 1994
16. Samson H, Files F, Brice G: Patterns of ethanol consumption in a continuous access situation: The effect of adding a sweetener to the ethanol solution. Alcohol Clin Exp Res 20:101-109, 1996
17. Litten RZ, Allen J, Fertig J: Pharmacotherapies for alcohol problems: A review of research with focus on developments since 1991. Alcohol Clin Exp Res 5:859-876, 1996
18. Zukin RS, Zukin SR: The case for multiple opiate receptors. Trends Neurosci 7:160-164, 1984
19. O'Brien CP, Volpicelli LA, Volpicelli JR: Naltrexone in the treatment of alcoholism: A clinical review. Alcohol 13:35-39, 1996
20. Kranzler HR, Burleson JA, Brown J, Babor TF: Fluoxetine treatment seems to reduce the beneficial effects cognitive-behavioral therapy in type-b alcoholics. Alcohol Clin Exp Res 20:1534-1541, 1996